Gary Gemignani

Gary Gemignani

Director of Finance/CFO at
Solta Medical, Inc.
60 year
Health Technology
Consumer Services
Finance

Profile

Gary G.
Gemignani
currently works at Algorithm Sciences, Inc., as Director from 2021, Laidlaw Venture Partners, as Director from 2021, and Solta Medical, Inc., as Chief Financial Officer & EVP from 2022.
Mr. Gemignani also formerly worked at IASO Pharma, Inc., as Director from 2010 to 2012, Bluejay Diagnostics, Inc., as Independent Director, Gentium Srl, as Chief Financial Officer & Executive Vice President, Biodel, Inc., as Chief Financial Officer from 2014 to 2016, Fortress Biotech, Inc., as Executive VP, Chief Operating & Financial Officer from 2010 to 2011, Champions Oncology, Inc., as Chief Financial Officer & Executive Vice President from 2011 to 2013, Synergy Pharmaceuticals LLC, as Chief Financial Officer & Executive Vice President from 2017 to 2019, Acacia Pharma Group Ltd., as Chief Financial Officer & Executive Vice President from 2020 to 2022, and Albireo Pharma, Inc., as Chief Financial Officer.
Mr. Gemignani received his undergraduate degree in 1987 from Saint Peter's University.

Gary Gemignani active positions

CompaniesPositionStart
Director/Board Member 03/10/2021
Director/Board Member 03/10/2021
Director of Finance/CFO 31/12/2021

Former positions of Gary Gemignani

CompaniesPositionEnd
ACACIA PHARMA GROUP PLC Director of Finance/CFO 22/03/2022
SYNERGY PHARMACEUTICALS INC Director of Finance/CFO 30/06/2019
CHAMPIONS ONCOLOGY, INC. Director of Finance/CFO 29/06/2013
FORTRESS BIOTECH, INC. Director of Finance/CFO 25/09/2011
GENTIUM S.P.A. (ADR) Director of Finance/CFO 30/03/2010
See the detail of Gary Gemignani's experience

Training of Gary Gemignani

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

47

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Gary Gemignani